|  November 23, 2014  |  
Mostly Cloudy   28.0F  |  Forecast »
Bookmark and Share Email this page Email Print this page Print Feed Feed

AT&T Selects WellDoc® Mobile Health Solution for Management of Chronic Diseases

Dallas, Texas, Baltimore, Maryland, October 13, 2010 --AT&T* and WellDoc®, a healthcare company that develops technology solutions to improve the lives of people with chronic diseases, today announced a strategic alliance to market and sell WellDoc’s mobile health (mHealth) solution in the United States to facilitate improved patient outcomes and reduce the spiraling costs of managing chronic diseases.

AT&T plans to deploy the WellDoc technology through an internal initiative with a select number of employees, using WellDoc DiabetesManager® System in 2011. AT&T will potentially expand to other disease areas (upon U.S. Food and Drug Administration (FDA) clearance), including: heart disease, asthma, chronic obstructive pulmonary disease and oncology. AT&T has a vested interest to help improve our employees’ health and quality of life and reduce healthcare expenditures. In 2009, AT&T offered medical, dental, life insurance, vision or disability benefits to some 1.2 million individuals – employees, retirees and their dependents. That includes approximately 686,000 employees and dependents and approximately 495,000 retirees and dependents.

"Chronic diseases account for $1.4 trillion of our nation’s healthcare spending according to PricewaterhouseCoopers. We believe that the use of mobile technologies and smart networks can contribute to a healthier world, and disease management is an area where mobility can facilitate improved patient outcomes and reduced healthcare costs,” said Dan Walsh, Senior Vice President, Marketing Services, AT&T Business Solutions. “By embedding tools on one of the most pervasive and ubiquitous technologies, the mobile phone, we hope to quickly unlock the enormous potential of mHealth. We chose WellDoc’s clinically validated solution as the lead disease management mHealth offer because it is an ideal solution for any company providing healthcare benefits.”

AT&T’s strategy is to extend its core communications capabilities to provide mHealth solutions, and as part of the multifaceted relationship with WellDoc, AT&T will jointly market and sell AT&T-WellDoc mHealth chronic disease solutions across the entire healthcare ecosystem, including payors, self-insured employers and disease management organizations. The WellDoc solution complements AT&T’s comprehensive portfolio of technology solutions for healthcare customers and gives enterprises a new mobile toolset to help manage populations. Operationally, AT&T will expand and scale WellDoc’s solution by utilizing AT&T’s mobility expertise, providing application hosting and creating a highly secure infrastructure to host critical health data. Commercially, AT&T will also support the solution with sales and marketing, customer care, provisioning and billing.

According to the Deloitte Center for Health Solutions, approximately 50 percent of consumers have expressed interest in home monitoring devices to check their condition and communicate the results to their doctor. Mobile technology, through the use of messaging and feedback via mHealth can play a key role in helping individuals with a chronic disease like diabetes make the appropriate lifestyle choices. The WellDoc DiabetesManager® System’s Web-based enterprise tools also enable providers and disease management organizations to more effectively oversee larger patient populations as the system automates and increases patient engagement.

“The alliance between AT&T and WellDoc is a landmark catalyst for the field of wireless health,” said Donald Casey, Chief Executive Officer at the West Wireless Health Institute. “The combination of two critical value chain elements – wireless expertise and clinical software excellence – is proof positive that the wireless healthcare space is rapidly approaching Main Street. These types of technologies have the potential to completely transform the management of our nation’s chronic disease epidemic.”

As announced in August, WellDoc became one of the first mHealth solutions to receive U.S. FDA 510(k) clearance. The system helps doctors and patients with type 2 diabetes work together by providing for the capture, storage and real-time transmission of blood glucose data and other diabetes self-management information in a highly-secure environment. This information is then analyzed by WellDoc’s proprietary Automated Expert Analytics SystemTM, which identifies trends and delivers relevant educational and behavioral patient coaching and provider decision support, thus enabling effective lifestyle and medication adjustments.

“We are proud to have been chosen by AT&T, a Fortune® 10 employer and world-class technology company, to market and sell our mHealth solution on such a wide scale,” said Dr. Anand K. Iyer, President and COO of WellDoc. “AT&T has long been a pioneer in investing in innovative technologies that provide the resources and infrastructure to support millions of customers. This relationship validates the DiabetesManager System as a mHealth solution that is here to stay, and we hope it empowers people with diabetes to manage their disease more effectively with their healthcare providers.”

*AT&T products and services are provided or offered by subsidiaries and affiliates of AT&T Inc. under the AT&T brand and not by AT&T Inc.

About WellDoc
WellDoc® a healthcare company that develops technology solutions to improve chronic disease management outcomes and reduce healthcare costs, is focused on simplifying the way chronic diseases are managed through a collaborative, life-changing approach that breaks down the barriers of engagement and therapy adherence by providing patients and their healthcare providers with real-time, actionable information. WellDoc has developed an industry-leading, technology-based solution that offers enterprise tools for payers and providers and helps people with chronic diseases better manage their conditions. For more information, visit www.welldoc.com.

About AT&T
AT&T Inc. (NYSE:T) is a premier communications holding company. Its subsidiaries and affiliates – AT&T operating companies – are the providers of AT&T services in the United States and around the world. With a powerful array of network resources that includes the nation’s fastest mobile broadband network, AT&T is a leading provider of wireless, Wi-Fi, high speed Internet and voice services. A leader in mobile broadband, AT&T also offers the best wireless coverage worldwide, offering the most wireless phones that work in the most countries. It also offers advanced TV services under the AT&T U-verse® and AT&T | DIRECTV brands. The company’s suite of IP-based business communications services is one of the most advanced in the world. In domestic markets, AT&T Advertising Solutions and AT&T Interactive are known for their leadership in local search and advertising. In 2010, AT&T again ranked among the 50 Most Admired Companies by FORTUNE® magazine.

Additional information about AT&T Inc. and the products and services provided by AT&T subsidiaries and affiliates is available at http://www.att.com. This AT&T news release and other announcements are available at http://www.att.com/newsroom and as part of an RSS feed at www.att.com/rss. Or follow our news on Twitter at @ATT. Find us on Facebook at www.Facebook.com/ATT to discover more about our consumer and wireless services or at www.Facebook.com/ATTSmallBiz to discover more about our small business services.

© 2010 AT&T Intellectual Property. All rights reserved. Mobile broadband not available in all areas. AT&T, the AT&T logo and all other marks contained herein are trademarks of AT&T Intellectual Property and/or AT&T affiliated companies. All other marks contained herein are the property of their respective owners.

Cautionary Language Concerning Forward-Looking Statements
Information set forth in this press release contains financial estimates and other forward-looking statements that are subject to risks and uncertainties, and actual results might differ materially. A discussion of factors that may affect future results is contained in AT&T's filings with the Securities and Exchange Commission. AT&T disclaims any obligation to update and revise statements contained in this news release based on new information or otherwise.

Add your comment:
Edit Module
Advertisement
Edit Module
Advertisement
Edit Module
Advertisement
Edit Module
Advertisement
Edit Module
Advertisement